Latest Articles
WHO links excess body fat to 13 cancers. Here's what it means for you - nation.co.ke
WHO links excess body fat to 13 cancers. Here's what it means for you nation.co.ke
Published: July 24, 2026, 3 a.m.
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators - Escuela Andaluza de Salud Pública
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators Escuela Andaluza de Salud Pública
Published: July 22, 2026, 9:19 a.m.
Mysuru hosts Women Cancer Summit 2026 - The Hindu
Mysuru hosts Women Cancer Summit 2026 The Hindu
Published: July 19, 2026, 1:53 p.m.
4 cancer death rates move against overall declining trend in Taiwan - Taiwan News
4 cancer death rates move against overall declining trend in Taiwan Taiwan News
Published: July 17, 2026, 3:40 a.m.
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial - BioPharm International
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial BioPharm International
Published: July 16, 2026, 9:06 p.m.
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer - Oncodaily
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer Oncodaily
Published: July 16, 2026, 4:40 p.m.
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer - CancerNetwork
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer CancerNetwork
Published: July 16, 2026, 3:40 p.m.
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Sahm
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Sahm
Published: July 16, 2026, 10:27 a.m.
Onconic's Nesuparib Targets 26 Trillion Won Endometrial Cancer Market, Backed by SCI Paper - Seoul Economic Daily
Onconic's Nesuparib Targets 26 Trillion Won Endometrial Cancer Market, Backed by SCI Paper Seoul Economic Daily
Published: July 16, 2026, 5:33 a.m.
Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype - londoninsider.co.uk
Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype londoninsider.co.uk
Published: July 15, 2026, 11:49 p.m.
Link copied to clipboard!